van der Graaf, Adriaan https://orcid.org/0000-0002-8898-8484
Warmerdam, Robert https://orcid.org/0000-0001-8691-0053
Auwerx, Chiara https://orcid.org/0000-0003-3613-8450
,
Boltz, Toni
Boomsma, Dorret I.
Brown, Andrew
Cheruiyot, Evans
Davenport, Emma E.
Dupuis, Théo
Esko, Tõnu
Farzeen, Aiman
Ferrucci, Luigi
Frayling, Timothy M.
Gibson, Greg
Gieger, Christian
van Greevenbroek, Marleen
Mishra, Binisha Hamal
Ikram, M. Arfan
Inouye, Michael
Jansen, Rick
Kähönen, Mika
Kukushkina, Viktorija
Lapinska, Sandra
Lehtimäki, Terho
Mägi, Reedik
Martinez-Perez, Angel
McRae, Allan F.
van Meurs, Joyce
Milani, Lili
Montgomery, Grant W.
Nagpal, Sini
Nauck, Matthias
Ophoff, Roel
Pasaniuc, Bogdan
Paul, Dirk S.
Persyn, Elodie
Peters, Annette
Prokisch, Holger
Raitakari, Olli T.
Raitoharju, Emma
Singleton, Andrew
Slagboom, Eline
Soria, José Manuel
Souto, Juan Carlos
Teumer, Alexander
Tokolyi, Alex
Veldink, Jan
Verlouw, Joost
Viñuela, Ana
Visscher, Peter M.
Völker, Uwe
Weiss, Stefan
Westra, Harm-Jan
Wood, Andrew R.
Xie, Manke
Võsa, Urmo
Borges, Maria Carolina
Franke, Lude https://orcid.org/0000-0002-5159-8802
Kutalik, Zoltán https://orcid.org/0000-0001-8285-7523
Article History
Received: 8 April 2024
Accepted: 5 June 2025
First Online: 3 July 2025
Competing interests
: The main authors of this study do not declare a competing interest. The authors of the eQTLGen consortium declare the following competing interests: B.M.P. serves on the Steering Committee for the Yale Open Data Access Project funded by Johnson & Johnson. This activity is unrelated to this work. M.I. is a trustee of the Public Health Genomics (PHG) Foundation, a member of the Scientific Advisory Board of Open Targets, and has a research collaboration with AstraZeneca that is unrelated to this study. D.S.P. is an employee and stockholder of AstraZeneca. The other authors of the eQTLGen consortium do not declare competing interests.